Analysts Viewpoint
Recent Insider Activity Could Benefit Cytokinetics Inc (CYTK)
In a filing, Cytokinetics Inc revealed its President & CEO Blum Robert I unloaded Company’s shares for reported $0.28 million
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.